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For years, the proliferative status of a tumour has been known to
have a profound effect on the outcome of both chemotherapy and
radiotherapy treatments (Shackney et al, 1978; McGuire and
Dressler, 1987; Chaval et al, 1989; Grogan et al, 1989; Hedley
et al, 1993a, 1993b; Begg, 1995). For example, both laboratory
and clinical data suggest that accelerated and/or hyperfractionated
radiotherapy schedules are better for the treatment of rapidly
proliferating tumours, while conventional daily radiotherapy
schedules are better for the treatment of slowly proliferating
tumours (e.g. Thames et al, 1983; Awwad, 1992; Begg et al, 1992;
Begg, 1995; Corro et al, 1995; Sarkaria et al, 1995). Similarly,
rapidly proliferating tumours respond better to cell cycle-specific
chemotherapeutic agents (e.g. 5-fluorouracil, 1-b-D-arabino-
furanosylcytosine (Ara-C), etc.), while slowly proliferating
tumours respond better to cell cycle-non-specific chemothera-
peutic agents (e.g. 1,3 bis-(2-chloroethyl)-1-nitrosourea (BCNU),
cisplatin (Cis-DDP), etc). Consequently, biomarkers of tumour
cell proliferation, particularly those that could be detected with
non-invasive imaging techniques, should be very useful in
selecting agents and/or schedules for treating a patient’s tumour.
To date, flow cytometric measurements of various cell cycle
parameters or biomarkers (e.g. S-phase fraction, proliferating cell
nuclear antigen (PCNA), Ki-67, potential doubling time (Tpot),
etc.) have been the most extensively studied predictors of tumour
cell proliferation (Hedley et al, 1993a, 1993b; Begg, 1995).
However, these flow cytometric predictors of outcome have met
with limited success in selecting anti-tumour agents or treatment
schedules for individual patients due to sampling and technical
problems (Dressler, 1993; Hedley et al, 1993b; Begg, 1995;
Haustermans et al, 1995; Tsang et al, 1995). Recently, we have
been studying sigma-2 receptors as possible biomarkers of tumour
cell proliferation because these receptors are potentially amenable
to detection by non-invasive imaging techniques (e.g. positron
emission tomography and single-photon emission tomography).
Using the well-characterized in vitro mouse mammary adenocarci-
noma model, line 66, proliferative (P) cells were shown to express
»10 times more sigma-2 receptors per cell than quiescent (Q) cells
(Mach et al, 1997). In addition, the kinetics for the loss of sigma-2
receptors from 66 Q-cells was identical to the kinetics for the loss
of PCNA from 66 Q-cells. However, these results were obtained
with a single rodent tumour cell line, so any suggestion that
sigma-2 receptors might be used as a universal biomarker of
tumour cell proliferation requires further investigation.
In the study presented here, several in vitro tumour models were
employed to test the hypothesis that the expression of sigma-2
receptors is predominantly influenced by a tumour cell’s ability to
progress through the cell cycle in a timely manner, and not by
other biological, physiological, or environmental properties of the
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NC 27157, USAtumour. Using mouse mammary adenocarcinoma cells, lines 66
and 67, 9L rat brain tumour cells, and MCF-7 human breast
tumour cells, the extent and kinetics of expression of sigma-2
receptors in P and Q tumour cells was studied as a function of
species, cell type, ploidy, pH, nutrient depletion, metabolic state,
recruitment from the Q-cell compartment to the P-cell compart-
ment, and treatment with tamoxifen. The data suggest that the
expression of sigma-2 receptors may indeed be a universal
biomarker of tumour cell proliferation, assuming that these in vitro
results can be duplicated in solid tumour models.
MATERIALS AND METHODS
Drugs
DTG (1,3-di-o-tolyguanidine) and (+)-pentazocine were
purchased from Research Biochemical International (Natick, MA,
USA). [3H]DTG was purchased from Dupont-NEN (Billerica,
MA, USA). Tamoxifen was purchased from Sigma Chemical
Company (St. Louis, MO, USA).
Cell culture procedures
The 66 (diploid) and 67 (aneuploid) cells in these experiments
were originally derived from a mouse mammary adenocarcinoma
and cultured in Waymouth’s medium supplemented with 3% fetal
calf serum, 6% newborn calf serum, 6% horse serum, 1% glut-
amine, 80.5 mg ml–1 of streptomycin and 80.5 units ml–1 of
penicillin as previously described (Wallen et al, 1984a, 1984b).
The 9L rat brain tumour cells were grown in BME supplemented
with 10% newborn calf serum, 1% glutamine, 80.5 mg ml–1 of
streptomycin and 80.5 units ml–1 of penicillin as previously
described (Wallen et al, 1980; Wheeler et al, 1992). MCF-7 cells
were grown in phenol red-free essential modified Eagle’s medium
(EMEM) supplemented with 10 mg ml–1 of bovine insulin, 1%
glutamine, 1% nonessential amino acids, 80.5 mg ml–1 of strepto-
mycin, 80.5 units ml–1 of penicillin and 5% calf serum that had
been treated with dextran-coated charcoal for 45 min at 55°C to
remove any endogenous hormones (Eckert and Katzenellenbogen,
1982; Katzenellenbogen et al, 1984; Berthois et al, 1986). All cells
were grown at 37°C in a 5% carbon dioxide atmosphere. At 3- to
6-month intervals, each cell line was rejuvenated from frozen
stock and tested for Mycoplasma (Mach et al, 1997).
With the exception of the recruitment experiments, exponen-
tially growing cells were trypsinized from stock cultures and
seeded at: (a) 1–2 ´ 105 cells per 25-cm2 flask in 5 ml of the appro-
priate medium for the growth curve experiments, and (b) 1–2 ´ 106
cells per 175-cm2 flask in 30 ml of the appropriate medium for the
sigma-2 receptor experiments. For the growth curve experiments,
three flasks were trypsinized at various times after seeding, the
cells were counted and sized on a Coulter counter/channelizer
system, and the mean ± 1 s.d. of the three counts was plotted as a
function of the incubation time. The doubling time was calculated
from a regression analysis of the day 1–4 data. In the sigma-2
receptor experiments, exponentially growing cells were obtained
from 17 ´ 175-cm2 flasks seeded 3 days prior to harvesting, and
plateau phase cells were obtained from 12 ´ 175-cm2 flasks seeded
at 5–12 days prior to harvesting, depending on which cell line was
used in the experiment.
Cell proliferation analysis
The percentage of 67, 66 and 9L cells labelled by a short (1 h) or
long (36 h) exposure to bromodeoxyuridine (BrdU) (10–5 M) was
determined flow cytometrically because the in vitro growth condi-
tions in these sigma-2 receptor experiments were slightly different
from those described previously (Wheeler and Wallen, 1980;
Wallen et al, 1984a, 1984b). Similar BrdU labelling experiments
were not performed for the MCF-7 cells because the in vitro
growth conditions were identical to those where the proliferation
kinetics had recently been determined by flow cytometrically
measuring the Ki-67 and idoxuridine (IdU) labelling index (Dong
et al, 1997).
Both unlabelled and BrdU-labelled cultures were handled iden-
tically. After trypsinization, the resulting single-cell suspensions
were gently centrifuged at 4°C, resuspended in phosphate-
buffered saline (PBS), and fixed in 70% ethanol at a final
concentration of 1–2 ´ 106 ml–1. For the flow cytometry analysis,
1.5 ´ 106 cells were first incubated for 20 min at 37°C with 0.2 mg
ml–1 of pepsin in 2 N HCl–PBS, washed twice in PBS containing
0.5% fetal bovine serum (FBS), and then incubated for 45 min
with a mouse anti-BrdU antibody conjugated to fluorescein isoth-
iocyanate (Boehringer-Mannheim, Indianapolis, IN, USA). The
cells were then washed in 1 ml of PBS containing 0.5% FBS and
0.5% Tween-20, incubated for 30 min in RNAase (1 mg ml–1) and
stained with propidium iodide (10 mg ml–1). All flow cytometry
was performed using a Coulter Epics flow cytometer equipped
with an air-cooled argon laser using an excitation wavelength of
488 nm. In each experiment, cells isolated from unlabelled 67, 66
and 9L cultures were handled as described above in order to set
the gating parameters that compensate for autofluorescence and
non-specific binding of the anti-BrdU monoclonal antibody.
Although exponentially growing 67, 66 and 9L tissue culture
cells that were pulse-labelled with BrdU contained as much BrdU
per cell as exponentially growing human tissue culture cells, the
background fluorescence due to autofluorescence and non-specific
binding of the monoclonal antibody to the 67, 66 and 9L tumour
cells was much higher than that seen with human cells because
the commercially available antibody was produced in mice.
Consequently, the signal to noise ratio was much less than that
normally obtained with human tumour cells. Two gating methods
were employed to estimate the percentage of BrdU–labelled cells
in each sample. The flow cytometry data was displayed either as a
bivarate distribution of the BrdU content as a function of the cell’s
position in the cell cycle or as a histogram of the BrdU content.
Gating parameters were selected so that ≤ 5% of the unlabelled
control cells had fluorescence intensities sufficient to be consid-
ered BrdU-labelled cells. Although both methods gave identical
results, a box analysis on the bivariate distributions was used to
generated the data in Table 1.
Determination of the sigma-2 receptor density
For each cell population, the tissue culture flasks were placed on
ice, the medium was removed, the flasks were rinsed with ice-cold
medium without serum, and the cells harvested with a plastic
scraper (Mach et al, 1997). In each experiment, the cells in three
additional 175-cm2 flasks were trypsinized, counted and their
protein content determined by the method of Bradford (1976). For
the various calculations, it was assumed that the number of
scraped cells per flask and their protein content were identical to
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membranes were prepared as previously described (Mach et al,
1997), and aliquots containing 1 mg ml–1 of protein were stored at
–80°C until assayed for sigma-2 receptors.
The sigma-2 receptor density was determined for each
membrane preparation as previously described by Mach et al
(1997). Briefly, 30–60 mg of protein was incubated with 4 nM
[3H]DTG and varying amounts of cold DTG (0.1–1000 nM) in the
presence of (+)-pentazocine (100 nM) to mask the sigma-1 sites.
Nonspecific binding was determined in the presence of 5 mM DTG.
After rapidly harvesting each sample on filters and counting the
radioactivity with a liquid scintillation spectrometer, the binding
data were analysed with the Scatchard program, EBDA (Biosoft,
Miltown, NJ, USA), using the COLD option to calculate the Bmax
values. The sigma-2 receptor density was then calculated as
previously described (Mach et al, 1997).
Experimental design
In order to determine the effect of ploidy on the expression of
sigma-2 receptors in P- and Q-cells, 17 flasks of aneuploid mouse
mammary adenocarcinoma cells, line 67, were seeded 3 days prior
to harvesting 12 flasks of 67 Q-cells. Thus, a 3-day P-cell popula-
tion could be analysed simultaneously with either a 7-, 10-, or
12-day Q cell population. The P- and Q-cells were harvested by
scraping, cell membranes were prepared, and the sigma-2 receptor
density was measured as previously described (Mach et al, 1997).
The results from the aneuploid 67 cells were compared to the
previously published results from the diploid 66 cells to determine
if ploidy influenced the expression of sigma-2 receptors in P and Q
mouse mammary adenocarcinoma cells.
In order to determine if the expression of sigma-2 receptors
followed the kinetics of recruitment of Q-cells back into the P-cell
compartment, 66 or 67 cells were trypsinized from 10-day cultures
and reseeded at 107 cells per 175-cm2 tissue culture flask (Wallen
et al, 1984b). The initial sigma-2 receptor density (day 0) was
determined on an aliquot of the 10-day Q cells that were used to set
the recruitment experiment. On day 2, 4, 7, 10, 14 and 17 after
subculturing, the cells were harvested by scraping, cell membranes
were prepared, and the sigma-2 receptor density measured as
previously described (Mach et al, 1997). The kinetics of the
expression of the sigma-2 receptors was then compared with the
population growth kinetics as the cells progressed from Q to P and
then back to Q.
In order to determine if factors such as cell–cell contact, nutrient
depletion, changes in metabolic state, or low pH (6.6–6.8) might
be responsible for the loss of sigma-2 receptors in plateau phase
cells, 9L rat brain tumour cells were seeded at 2–3 ´ 106 cells per
175-cm2 flask. These 9L cells grew exponentially for 3–4 days
before reaching a plateau on day 5 that results from an equilibrium
between the addition of 9L cells to the culture through cell division
and loss of 9L cells from the culture through cell death and lysis
(Wheeler and Wallen, 1980). On day 5 after subculture, all of these
9L cells appeared healthy, even though a few of these cells were
clonogenically dead or dying. By day 7, 50% of the 9L cells were
rounded up and in the final stages of cell death because the glucose
in the medium had been depleted (Li, 1982a, 1982b). The clono-
genic efficiency of these 7-day 9L cells was < 1%. The sigma-2
receptor density of 3-day 9L cells was 6.3 times greater than the
sigma-2 receptor density of these nonclonogenic 7-day 9L cells.
Consequently, if the sigma-2 receptor density remained relatively
constant for day 3 and day 5 9L cells, cell–cell contact, nutrient
depletion, metabolic state and low pH (6.6–6.8) are not likely to
have much influence on the expression of sigma-2 receptors in
solid tumours.
In order to determine if changes in the sigma-2 receptor density
mimic changes in the proliferative status of tumour cells after
treatment with chemotherapeutic agents, oestrogen-responsive
MCF-7 cells obtained from the American Type Tissue Culture
repository were seeded at 2 ´ 106 cells per 175-cm2 flask and
grown for 3 days in phenol red-free medium containing charcoal
scrubbed serum (Berthois et al, 1986). A 10 mM stock solution of
tamoxifen was prepared in ethanol and stored at –20°C. On day 3,
the tamoxifen stock solution was diluted in ethanol and added to
the culture medium to produce a final tamoxifen concentration of
1n M and a final ethanol concentration of 0.1%. In some experi-
ments, the medium containing tamoxifen was removed on day 6,
and the cells retreated for another 3 days with fresh medium
containing 1 nM tamoxifen. On day 6 and day 9 after seeding, both
untreated and tamoxifen treated cells were harvested by scraping,
cell membranes were prepared, and the sigma-2 receptor density
was determined as previously described (Mach et al, 1997). The
reduction in the sigma-2 receptor density measured in these
experiments was then quantitatively compared to the reduction in
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Table 1 Summary of the percentage of BrdU-labelled cells obtained when
exponential and plateau phase 67, 66 and 9L tissue culture cells were
exposed to 10–5 M BrdU for 1 h or 36 h
BrdU exposure time
Cells Days in culture 0 h 1 h 36 h
67 3 3.2 39.7 44.1
10 1.1 4.3 6.1
66 3 2.1 35.1 63.0
10 0.3 1.9 9.5
9L 3 3.1 16.7 89.2
5 5.0 21.2 68.1
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Figure 1 In vitro growth curve for aneuploid mouse mammary
adenocarcinoma cells, line 67. Each data point represents the mean ± 1 s.d.
of the cell counts in three independent experiments. If not shown, the error
bars lie within the data point. The population doubling time (TD) was
determined from a least squares linear regression analysis of the natural log
transformation of the day 1–4 data928 I Al-Nabulsi et al
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Figure 2 Flow cytometric determination of the percentage of labelled cells obtained when exponential or plateau phase cultures of 67 and 9L cells were
exposed to 10–5 M BrdU for 1 h or 36 h. Each dot within the box represents a cell that is considered to have been labelled by BrdU and is, therefore, a
proliferating cell. The gating parameters were chosen so that ≤5% of a population of cells that had not been exposed to BrdU resided in the box (left panels)the Ki-67 labelling index, AgNOR scores, and IdU-labelling index
recently reported for these MCF-7 cells treated with 4-hydroxy-
tamoxifen under identical conditions (Dong et al, 1997).
RESULTS
Effect of ploidy on the expression of sigma-2 receptors
during the P to Q transition
The 67 cells in these experiments grew exponentially for 4 days
with a population doubling time of 15.8 ± 0.3 h (Figure 1). After
day 5, there was a slight reduction in the number of cells per flask
until a stable plateau phase was reached by day 7. Both the shape
of the growth curve and the population doubling time for these 67
cells were identical to those previously published by Wallen et al
(1984a).
The percentage of 67 cells in day 3 cultures that were labelled
by a 1 h pulse of BrdU in 175-cm2 flasks (»39%) was slightly
lower than that expected for an exponentially growing population
with a doubling time of 16 h (Figures 1 and 2, Table 1). In day 10
cultures, about 4% of these 67 cells appeared to be lightly labelled
by a 1 h BrdU pulse (Figure 2, Table 1). Few, if any, additional 3-
day or 10-day 67 cells were labelled by a 36 h exposure to BrdU
(Table 1) indicating that > 90% of these 67 cells would enter the Q-
state after the next division (day 3 cultures) or were already in the
Q-state (day 10 cultures). Although the percentage of proliferating
cells in these day 10 cultures (»6%) was slightly greater than that
previously reported by Wallen et al (1984a), it is consistent with
the shape and kinetics of the growth curve for 67 cells shown in
Figure 1.
All Bmax values for the aneuploid 67 cells (Table 2) were slightly
larger than the Bmax values previously reported for the diploid 66
cells (Mach et al, 1997). However, the 67 P- and 67 Q-cells were
slightly smaller than the corresponding 66 P- and 66 Q-cells
(Wallen et al, 1984a). Consequently, the slightly higher Bmax values
for the 67 cells was offset by the smaller size of the 67 cells when
the sigma-2 receptor density was calculated on a per cell basis. In
these experiments, 3-day 67 P-cells had 300 000–800 000 sigma-2
receptors per cell (Table 1); a range identical to that previously
reported for the diploid 66 P-cells (Mach et al, 1997). The 7-
to 12-day Q-cells had 50 000–120 000 sigma-2 receptors per cell
(Table 1); a range identical to that previously reported for the
diploid 66 Q-cells (Mach et al, 1997). The P:Q ratio, expressed on
a receptor per cell basis, was much greater than the Bmax P:Q ratio,
because 67 P-cells had a higher protein content than 67 Q-cells
(Table 2). The P:Q ratio, expressed on a receptor per cell basis, did
not reach the maximum of » 8 until day 10, even though > 90% of
these 67 cells were in a quiescent state by day 7 (Figure 1, Table 1)
(Wallen et al, 1984a). Although the number of sigma-2 receptors
per P-cell, the number of sigma-2 receptors per Q-cell and the
maximum P:Q ratio were identical for both the 66 and 67 cell
lines, the 67 cells appeared to reach the maximum P:Q ratio
slightly faster than the 66 cells (Figure 3). This is consistent with
the 36 h BrdU labelling data in Table 1 which indicated that 3-day
67 cells underwent only one more division before the majority
entered quiescent, while 3-day 66 cells underwent two divisions
before the majority entered quiescence.
Expression of sigma-2 receptors during the Q to P to Q
transitions
When day 10 66 Q- and 67 Q-cells were trypsinized and reseeded
at a concentration of 107 cells per 175 cm2 flask, the Q-cells
rapidly entered the P-cell compartment with little or no delay
(Figure 4). The kinetics of the expression of sigma-2 receptors in
both 66 and 67 cells followed the population growth kinetics as
expected (Figure 4). There was a rapid increase in the sigma-2
receptor density during the exponential growth phase that levelled
off during early plateau phase and then decreased during late
plateau phase. Although the kinetics of the expression of sigma-2
receptors followed the population growth kinetics, the decrease in
the sigma-2 receptor density in late plateau phase did not start until
day 10–12 after subculturing the Q-cells (Figure 4). Thus, the
decrease in the sigma-2 receptor density occurred 3–5 days later if
Expression of sigma-2 receptors in tumour cells 929
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Table 2 Summary of the s2 receptor analyses for 3-day 67 P-cells and
either 7-day, 10-day, or 12-day 67 Q-cellsa
Bmax
(fmol mg–1 protein) Receptors per cell
3-day P-cells 7937 ± 987 533 204 ± 178 809
7-day Q-cells 4989 ± 1465 89 362 ± 29 172
P:Q ratio 1.66 ± 0.11 5.99 ± 0.27
3-day P-cells 8652 ± 988 348 655 ± 178 809
10-day Q-cells 5045 ± 1374 51 865 ± 11 706
P:Q ratio 2.02 ± 0.21 7.74 ± 0.64b
3-day P-cells 12 824 ± 1328 856 505 ± 243 956
12-day Q-cells 6032 ± 2061 116 128 ± 67 099
P:Q ratio 2.36 ± 0.28 8.65 ± 1.16c
aAll values are the mean ± 1 SE from at least three independent experiments.
The P-cells experiments were run simultaneously with the corresponding
Q-cell experiments. bValue statistically different from 7-day P:Q ratio;
P < 0.02. cValue statistically different from 7-day P:Q ratio; P < 0.03, but not
statistically different from 10-day P:Q ratio; P > 0.4.
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Figure 3 Ratio of the sigma-2 receptor density in 3-day 66 or 67 P-cells to
the sigma-2 receptor density in 7-, 10- or 12-day 66 or 67 Q-cells. Each data
point is the mean ± 1 s.d. of the P:Q ratios obtained in three independent
experiments. If not shown, the error bars lie within the data pointthe cultures were set from 10-day Q-cells than if the cultures were
set from 3-day exponentially growing P-cells.
Effect of physiological and environmental factors on
the expression of sigma-2 receptors
9L cells in 5-day cultures exist in medium that is virtually depleted
of glucose and has a pH of 6.6–6.8 (Li, 1982a, 1982b; Zhang and
Wheeler, 1994). These plateau phase cells grow in layers that are
several cells thick and have a metabolism that is substantially
reduced from that of exponentially growing cells (Wheeler et al,
1992). Finally, virtually the same number of cells labelled by a 1 h
pulse of BrdU in day 3 and day 5 cultures (Table 1) indicates that
day 4–6 plateau phase cultures result from an equilibrium between
cell division and cell death as previously described (Wheeler and
Wallen, 1980). The slight reduction in the number of cells labelled
by a prolonged 36 h exposure to BrdU from 89% in 3-day cultures
to 68% in 5-day cultures (Table 1) is also expected if the 9L
plateau phase results from an equilibrium between cell division
and cell death. Consequently, all of the physiological and environ-
mental factors that might have modulated the sigma-2 receptor
density of 66 and 67 cells in 7- to 12-day cultures are present in
5-day cultures of 9L cells; however, none of these 5-day 9L cells
have entered a true quiescent state. The Bmax and the sigma-2
receptors per cell ratios for 3-day exponential and 5-day plateau
phase 9L cells was 1.01 ± 0.04 and 1.36 ± 0.08 respectively
(Table 3). For comparison, day 7 66 and 67 cells had exponential
to plateau phase ratios of 2.8 (Mach et al, 1997) and 5.99 (Table 2)
respectively. The slight decrease in the sigma-2 receptor density of
the 5-day 9L cells (Table 3) probably occurred because a few of
these 9L cells were clonogenically dead or dying. As described in
Materials and Methods, non-clonogenic 9L cells have a lower
sigma-2 receptor density than clonogenic 9L cells.
Effect of cytotoxic concentrations of tamoxifen on the
expression of sigma-2 receptors
Exposing day 3 cultures of oestrogen-responsive MCF-7 cells to
1n M tamoxifen for either 3 or 6 days resulted in a virtual cessation
of cell division (Figure 5). The number of MCF-7 cells recovered
from the tamoxifen treated flasks on days 6 and 9 was not statisti-
cally different (P > 0.05) from the number of MCF-7 cells recov-
ered from untreated flasks on day 3. By day 9, there was a 50%
decrease in cell growth in the tamoxifen-treated flasks (Figure 5).
No appreciable difference in the cell cycle distribution of the
untreated or tamoxifen-treated cells was observed suggesting that
few, if any of these MCF-7 cells, entered a true quiescent state
(data not shown). However, there was a reduction in the number of
sigma-2 receptors per cell after 3 or 6 days of treatment with 1 nM
tamoxifen (Table 4). The average reduction in the sigma-2
930 I Al-Nabulsi et al
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Figure 4 Comparison of the population growth kinetics and the kinetics of
expression of sigma-2 receptors when 10-day 66 Q-cells (upper panel) or 67
Q (lower panel) were recruited back into the P-cell compartment by
subculturing. Each data point represents the mean ± 1 s.d. of the values from
two independent experiments. If not shown, the error bars lie within the data
point
Table 3 Expression of sigma-2 receptors in exponentially growing and
plateau phase 9L rat brain tumour cells
Days in culture Bmax (fmol mg–1) Receptors per cell
(X ± 1 s.d.) (X ± 1 s.d.)
3-day 3239 ± 672 341 183 ± 22 263
5-day 3200 ± 178 251 358 ± 23 568
Exp:Plat 1.01 ± 0.04 1.36 ± 0.08
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Figure 5 In vitro growth curves for aneuploid MCF-7 human breast tumour
cells with (s) and without (•) continuous exposure to 1 nM tamoxifen starting
on day 3 after subculturing from exponentially growing cells. Each data point
represents the mean ± 1 s.d. of the cell counts from 2–3 independent
experiments. If not shown, the error bars lie within the data pointreceptor density was 1.52 ± 0.41 after a 3-day exposure to 1 nM
tamoxifen, and 2.23 ± 0.41 after a 6-day exposure to 1 nM
tamoxifen. These values compare favourably with the reduction
in the Ki-67 labelling index (1.24), AgNOR scores (1.32) and
IdU–labelling index (2.36) reported by Dong et al (1997) for
oestrogen-responsive MCF-7 cells whose growth had been
reduced by 50% after exposure to 0.1–1.0 mM 4-hydroxy-
tamoxifen.
DISCUSSION
Sigma receptors were originally described as a subtype of the
opiate receptors. Subsequent studies demonstrated that sigma
receptors represented a distinct class found in a variety of tumours
and normal tissues (Walker et al, 1990). Two types of sigma recep-
tors have been identified. Sigma-1 receptors have a molecular
weight of 25 kDa; sigma-2 receptors have a molecular weight of
18–21 kDa (Walker et al, 1990; Hellwell et al, 1994). In general,
tumour cells have been reported to have more sigma-2 receptors
than sigma-1 receptors (Bem et al, 1991; Vilner and Bowen, 1992;
Vilner et al, 1995), and in at least one case, MCF-7 cells, it has
been reported that sigma-1 receptors are undetectable (Vilner et al,
1995). Consequently, our studies have emphasized the establish-
ment of a relationship between the density of sigma-2 receptors
and the proliferative status of tumour cells because such a relation-
ship is more likely to occur in a variety of human cancers.
At the present time, sigma-2 receptors have no known function,
have no known endogenous ligand and have not been cloned. Our
initial study with mouse mammary adenocarcinoma cells, line 66,
indicated that proliferative tumour cells expressed about ten times
more sigma-2 receptors per cell than quiescent tumour cells
(Mach et al, 1997). In addition, the kinetics for the loss of sigma-2
receptors appeared to be identical to the kinetics for the loss of
PCNA from these 66 Q-cells. Although these data suggested that
sigma-2 receptors might be a biomarker of tumour cell prolifera-
tion, there were many biological, physiological and environmental
factors other than progression through the cell cycle that could
have been responsible for either the overexpression of sigma-2
receptors in 66 P-cells or the decreased expression of sigma-2
receptors in 66 Q-cells.
Among the biological reasons for the results with the 66 line
was the possibility that the relationship between the expression of
sigma-2 receptors and cell proliferation would be limited to
diploid, rodent breast cancer lines. In addition, sigma-2 receptors
might be a biomarker of the P to Q transition, but not of the Q to P
transition. This would certainly limit the usefulness of sigma-2
receptors as a biomarker of tumour cell proliferation during and
after therapy. There were also physiological and environmental
factors that could have caused the apparent relationship between
the expression of sigma-2 receptors and cell proliferation. For
example, the metabolic status of these tumour cells could be dras-
tically altered under nutrient depletion or low pH conditions, even
though these cells may continue to progress through the cell cycle.
If the expression of sigma-2 receptors reflected primarily changes
in the metabolic state of the cells or the composition and pH of the
surrounding milieu, sigma-2 receptors would not always be a
biomarker of tumour cell proliferation.
In the study reported here, P-cells of the aneuploid mouse
mammary adenocarcinoma line 67 had about eight times more
sigma-2 receptors per cell than the Q-cells (Table 2); a result
essentially identical to that previously reported for the diploid 66
line (Mach et al, 1997). Thus, ploidy did not appear to substan-
tially influence the expression of sigma-2 receptors. This is partic-
ularly important if radioligands selective for sigma-2 receptors are
going to be used to assess the proliferative status of human breast
tumours because 25–30% of human breast tumours are comprised
of predominantly aneuploid tumour cells, 25–30% are comprised
of predominantly diploid tumour cells, and 30–40% contain
substantial populations of both aneuploid and diploid tumour cells.
In many tissue culture models, there is a strong relationship
between cell–cell contact, nutrient depletion, low pH, metabolic
state and cell proliferation. In general, as cell–cell contact
increases and nutrients are depleted from the medium, the pH, cell
metabolism and cell proliferation decreases. 9L rat brain tumour
cells are somewhat unique in that they will grow exponentially
with their normal doubling time at pH 6.6–6.8, thereby forming a
monolayer that is several cells thick (Zhang and Wheeler, 1994).
As the glucose is depleted from the medium, the oxygen consump-
tion of these 9L cells decreases and other sources of energy such as
succinate are utilized if they are present (Wheeler et al, 1992).
Although day 4 and day 5 9L cells have a distinctly altered metab-
olism, 9L cells continue to progress through the cell cycle at nearly
a normal rate (Figure 2 and Table 1). When the glucose is suffi-
ciently depleted (day 5–6), these 9L cells rapidly progress to death
and lysis, rather than entering a quiescent state (Li, 1982a, 1982b).
Death occurs at all phases of the cell cycle within 24 h, not just in
M or G1. In the present study, day 5 9L cells which had existed at
pH 6.6–6.8 for at least 48 h, were in a monolayer several cells
thick, had a reduced metabolism from the day 3 cells, and existed
at a glucose concentration that would result in the 60–80% normal
clonogenic efficiency being reduced to < 1% within the next 48 h.
None of these physiological or environmental factors resulted in a
change in the sigma-2 receptor density from that found in day 3
exponentially growing 9L cells (Table 3). Consequently, this result
suggests that cell–cell contact, nutrient depletion, low pH and
altered metabolic states are not likely to be important regulators of
the sigma-2 receptor density in tumour cells.
Although the 66, 67, and 9L data strongly support the hypoth-
esis that the density of sigma-2 receptors in tumour cells reflects
solely their proliferative status, the information will be useless
unless the expression of the sigma-2 receptors matches changes in
the proliferative status observed after treatment with various anti-
cancer agents. It is well known that recruitment of Q-cells back
into the P-cell compartment is a major event in the regrowth of a
tumour after treatment. When both 66 and 67 Q-cells were
recruited back into the P-cell compartment by subculturing, the
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Table 4 Effect of tamoxifen on the expression of sigma-2 receptors in MCF-
7 human breast tumour cells
Days in culture Experiments Sigma-2 receptors per cell
(untreated:treated)
6-daya A 2.05 ± 0.11
B 1.28 ± 0.11
C 1.24 ± 0.13
Average 1.52 ± 0.41
9-dayb B 2.51 ± 0.33
C 1.95 ± 0.28
Average 2.23 ± 0.41
aCells were treated with tamoxifen (1 nM) on day 3 after seeding. bCells were
treated with tamoxifen (1 nM) on day 3 and day 6 after seeding.sigma-2 receptor density increased rapidly, reached a maximum in
2–4 days, and then decreased after the cells entered quiescence
with kinetics that were similar to those previously described for
these same cells during the P to Q transition (Figure 4 and Table 2)
(Mach et al, 1997). Thus, the kinetics of the expression of sigma-2
receptors matched the population growth kinetics when 66 and 67
Q-cells were recruited back into the P-cell compartment. It is also
well known that many anticancer agents have cytostatic effects as
well as cytotoxic effects. For example, at low concentrations of
tamoxifen, human breast tumour cells stop progressing through
the cell cycle or do so only very slowly (Katzenellenbogen et al,
1984). At high concentrations of tamoxifen, human breast tumour
cells are killed (Katzenellenbogen et al, 1984). When MCF-7
human breast tumour cells were treated in our study with a cyto-
static concentration of tamoxifen, the sigma-2 receptor density
was reduced to the same extent (Table 4) as the Ki-67-labelling
index, AgNOR scores and IdU-labelling index reported by Dong
et al (1997). Taken together, these data suggest that the sigma-2
receptor density will likely reflect the proliferative status of
human tumours before, during and after treatment with anticancer
agents.
In summary, the hypothesis that the expression of sigma-2
receptors is predominantly influenced by a tumour cell’s ability to
progress through the cell cycle in a timely manner, and not by
other biological, physiological, or environmental properties was
tested by comparing: (a) the expression of sigma-2 receptors in
diploid (66) and aneuploid (67) mouse mammary adenocarcinoma
cells, (b) the expression of sigma-2 receptors in exponentially
growing and plateau phase 9L rat brain tumour cells, (c) the
kinetics of expression of sigma-2 receptors with the population
growth kinetics obtained when 10-day 66 Q- or 67 Q-cells were
recruited back into the P-cell compartment, and (d) the reduction
of the expression of sigma-2 receptors with the reduction of other
biomarkers of cell proliferation after treatment of MCF-7 human
breast tumour cells with cytostatic concentrations of tamoxifen. It
should be emphasized that the above tests of the hypothesis
involved tumour cells from three species (mouse, rat and human),
two tumour cell types (breast and brain) and tissue culture models
where the proliferative status of the cells changed drastically,
slightly, or not at all. In every case, the expression of the sigma-2
receptors solely reflected the proliferative status of the tumour
cells. Consequently, all of the data support the hypothesis that the
expression of sigma-2 receptors is predominantly influenced by a
tumour cell’s ability to progress through the cell cycle in a timely
manner, and suggest that sigma-2 receptors may be a universal
biomarker of cell proliferation. If the in vitro results reported here
can be demonstrated in solid tumours, then it should be possible to
non-invasively assess the proliferative status of tumours and
normal tissues using radioligands that selectively bind to sigma-2
receptors.
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